Skip to main content
Submitted by Dr S. Patel on 5 June 2018
Image: Stock photo of colon over white t-shirt and dark jeans set against a pink background

Colorectal cancer is the 4th most common cause of deaths related to cancer worldwide. Lynch syndrome or HNPCC is one of most common genetic causes of Colon cancer. Here are a few questions to better understand Lynch syndrome and how we can screen for it.

1. What is the Lynch syndrome? Which genes are involved?

Lynch Syndrome is also known as hereditary non-polyposis colorectal cancer or HNPCC. It has a genetic disposition, hence the term hereditary and is known to be associated or  the causative factor for various cancers including endometrial (second most common), ovarian, stomach, small intestine, hepatobiliary tract, upper urinary tract, skin and brain. It is an autosomal dominant genetic condition, which means that the gene defect can be passed down to the child even if only one parent has the mutated gene. Just one copy of the mutated gene is sufficient to develop cancer. Gene mutation is the permanent alteration in the DNA sequence that makes up a gene. Individuals who are carriers of such a mutated gene have a higher than normal chance of developing colorectal and the various cancers mentioned above, often at a young age. The early age onset, sporadic occurrence and right-sided colon lesions are discovered to be characteristic to Lynch syndrome. [Image result for lynch syndrome]

Genes currently known to be susceptible for Lynch syndrome include MLH1, MSH2, MSH6, PMS2, and EPCAM. 

2. What are signs and symptoms of Lynch syndrome?

It is recommended that one watch out for any signs and symptoms of colon and endometrial cancer. People with Lynch syndrome have the following risk factors:

  • Personal history of multiple gastrointestinal polyposis.
  • History of colon or gastrointestinal cancer at a younger age, especially before age of 50 years. 
  • Personal history of any of the following cancers: endometrial cancer, ovarian cancer, kidney cancer, stomach cancer, small intestine cancer, liver cancer, sweat gland cancer (sebaceous carcinoma), skin or brain.
  • Family history of colon or endometrial cancer under the age of 50.
  • 1 or more 1st or 2nd degree relative with colorectal or Lynch syndrome associated cancers. 
  • 2 or more 1st or 2nd degree relative with colorectal or Lynch syndrome associated cancers.

3. How common is the Lynch syndrome in India?

There are several inherited syndromes that can lead to increased risk of colon cancer, of which Lynch syndrome is the most common.

Statistics says that approximately 3 out of every 100 colon cancers are due by Lynch syndrome. In India, the annual incidence rate of Colon cancer is 4.4 per 100,000 in men and 3.9 per 100,000 in women. Approximately 5% of all colon cancers are attributed to genetic predisposition of Lynch syndrome.

4. Does Lynch syndrome affect every generation?

Yes. It does not skip generations. Both sexes can have Lynch syndrome and it may pass to any of their children.

5. How can a mother prevent passing on the gene to her child? How does preimplantation genetic diagnosis work for Lynch syndrome?

Mother can prevent passing unwanted genes to her child by doing preimplantation genetic diagnosis (PGD). Preimplantation genetic diagnosis is the procedure used to identify any genetic defects in an embryo. Embryos are usually made via the in vitro fertilization (IVF), tested at day 5 and only the desired embryos free of genetic problems are implanted into the uterus. Since the procedure is carried out before implantation, a couple has the choice of whether they want to start the pregnancy or not.

PGS or preimplantation genetic screening, is a procedure where all the embryos (produced by IVF) are checked for genetic diseases, so that the best embryo is then selected.

6. How is Lynch syndrome diagnosed?

After the tumor has been found via physical examination and colonoscopy, Lynch syndrome can be confirmed via tumor tissue testing from a biopsy. This is carried out for any individual who is suspected of having Lynch syndrome.

The two tumor tissue tests available are:

  • Microsatellite instability (MSI) test where a dye is used to check for missing proteins.
  • Immunohistochemistry (IHC) test determines instability in the DNA sequence.

Genetic testing of blood samples is commonly done to check for heritable mutations. Molecular genetic testing is necessary to confirm diagnosis of Lynch syndrome.

7. When and when should one start screening for it?

Families with Lynch syndrome and family members tested positive for gene mutation and those who have not been tested, should start colonoscopy screening during their early 20s, or 2 to 5 years younger than the youngest person in the family with a diagnosis (whichever is earlier). 

  • Colonoscopy should be done every 1 or 2 years. If there are any polyps present, they can be detected and removed. This helps find any early cancers too. People known to carry one of the gene mutations may also be given the choice of having surgery to remove most of the colon as a prophylactic measure.
  • Women are also recommended to inform their Gynecologist and get a transvaginal ultrasound or endometrial biopsy done every year after the age of 30.

8. If a person has been detected with the HPNCC genes, what preventive/ prophylactic measures are offered to the person?

  • Subtotal colectomy with ileorectal anastomosis (i.e. removal of subtotal colon and to join with rectum) and after that there is surveillance for rectum.
  • Or total colectomy with permanent ileostomy (removal of entire large colon and small bowel is put outside abdominal wall to pass stool and flatus permanently). This operation may be considered for prophylaxis in selected mismatch repair (MMR) gene mutation carriers.
  • Women may choose to have a hysterectomy (removal of the womb) or oophorectomy (removal of the ovaries). Such measures are recommended only after women have completed their families and do not prefer regular screening.

9. How much does genetic testing cost?

Testing of MLH1 is around 30,000/ rupees in India. If you have Lynch syndrome, each of your children have a 50% chance of acquiring the mutated gene. Children over the age of 18 can undergo genetic testing.

10. Can Lynch syndrome also cause Breast cancer?

The estimates of an increased risk of breast cancer in Lynch syndrome is relatively small compared with the increased risks observed for colorectal and endometrial cancers. 

It has a risk of around 12%.

11. What is the prognosis for Lynch syndrome-associated cancers?

Prognosis for Lynch Syndrome is,

  • Ten-year survival was 87% after any cancer.
  • 91% if the first cancer was colorectal.
  • 98% if endometrial and 89% if ovarian cancer..

References:

  1. Indian Council of Medical Research http://www.icmr.nic.in/guide/cancer/Colorectal/
  2. https://www.cancer.net/cancer-types/lynch-syndrome
  3. MedIndia, network for Health. https://www.medindia.net/patientinfo/lynch-syndrome.htm
  4. American Pregnancy Association. www.americanpregnancy.org

 

Community

Stories

  • Profile picture of Uday Kerwar Bladder cancer survivor and Ostomy India Chairperson framed in a blue background with the bladder cancer tricolour ribbon
    You Adapt To The Bladder Bag Like You Do To Eye-Glasses
    Uday Kerwar, survivor of stage 4 bladder cancer and currently Chairman of Ostomy Association of India (OAI) talks about his journey with bladder cancer, urostomy bags, its many challenges and plenty of adjustments before it becomes a part of you. Please tell us a little about yourself.  I am 62 and retired. Since 2016 I am continuously associated with Ostomy Association of India (OAI), a Charitable Trust providing rehabilitative support to people who have undergone Ostomy (life-saving…
  • Head shot of a bespectacled woman wearing a black and red dress and red necklace
    मेरे ब्रेन ट्यूमर के निदान ने मुझे बोल्ड बना दिया
    जब बेंगलुरु की 38 वर्षीया ए चित्रा को सीज़र होने लगे, तो शुरू में उनका एपिलेप्सी (मिर्गी) के लिए इलाज किया गया, लेकिन अंततः उन्हें मैलिग्नेंट ग्लियोमा (एक प्रकार का ब्रेन ट्यूमर) का निदान मिला। वे बताती हैं कि कैसे उन्होंने डॉक्टरों, परिवार, दोस्तों और अपनी कंपनी की टीम के समर्थन से अपनी बीमारी के उपचार और भावनात्मक पीड़ा को संभाला। कृपया हमें अपनी स्थिति के बारे में कुछ बताएं मुझे एनाप्लास्टिक एस्ट्रोसाइटोमा ग्रेड 3 नामक ब्रेन ट्यूमर का निदान मिला था। यह एक दुर्लभ, मैलिग्नेंट ट्यूमर है जिसे…
  • ब्रेन ट्यूमर होने के बाद मेरी पहली प्राथमिकता मेरा स्वास्थ्य है
    30 वर्षीय मेल्विन जॉर्ज इस लेख में एस्ट्रोसाइटोमा (एक प्रकार का ब्रेन ट्यूमर) का निदान प्राप्त करने, देखभाल के विकल्पों का आकलन करने और निर्णय लेने, और कैंसर के उपचार और सम्बंधित दुष्प्रभाव पर चर्चा करते हैं और साझा करते हैं  कि इन सब अनुभव और चुनौतियों ने उन्हें व्यक्तिगत रूप से कैसे प्रभावित किया और रिकवरी में उनकी आस्था उनका मुख्य सहारा कैसे बनी रही।  चौंकाने वाला निदान 11 जुलाई 2017 का दिन। मैं अपने छात्रावास के कमरे में अपने बिस्तर पर लेटा हुआ था और जैसे ही मैं जाका, मैंने देखा…
  • The author, a woman in a red and yellow sari and a yellow blouse, holding birds
    मैंने अपनी आवाज पैसिव स्मोकिंग (निष्क्रिय धूम्रपान) के कारण खो दी
    धूम्रपान न करने वाली 72 वर्षीया नलिनी सत्यनारायण को 10 साल पहले उनके घर में सेकेंड हैंड धुएं के संपर्क में आने के कारण गले (वॉयस बॉक्स) के कैंसर का निदान मिला। आज, उत्तरजीवी के रूप में, वे एक ऊर्जावान तंबाकू नियंत्रण योद्धा बन गई हैं और ऐसे लोगों को परामर्श देती हैं जिन्होंने स्वरयंत्र (लैरिन्क्स) की सर्जरी करवाई है जिसमें उनका वॉयस बॉक्स हटाया गया है - वे उन्हें कृत्रिम वॉयस बॉक्स से बात करना सिखाती हैं। आपने कब और कैसे अपने गले की समस्या को पहचाना? जनवरी 2010 की बात है। मुझे लगा कि मेरा गला…
  • Should Time Toxicity Be A Factor In Informed Decision Making?
    Patients with advanced cancers often contemplate the time burden of their cancer care. What does this exactly entail? Dr Arjun Gupta, an Oncologist and Researcher, recently wrote a paper about Time Toxicity for Cancer patients. He helps us understand this new concept and how it can affect quality of life for patients. What is ‘’time toxicity’’? We have seen tremendous progress in oncology in the past few decades. Yet, for advanced solid cancers, average survival benefits offered by new…
  • Webinar: Ovarian Cancer Awareness and Management
    This webinar is not just for Ovarian Cancer survivors but also for survivors of breast cancer, uterine cancer, colorectal cancer and all women at risk of Ovarian Cancer. Ovarian Cancer is a difficult to diagnose cancer. So it is very important for us to be aware of the surprising symptoms of Ovarian cancer. We must also know the factors that increase risk. Additionally, in COVID times, it is important to understand how to continue treatment and when you should vaccinate. We bring together a…
  • Coping with Colon Cancer with some Filmi Tadka - Webinar VIDEO
    Mr Ramendra Kumar will speak with Aparna Mittal, founder PatientsEngage on his tryst with Colon cancer, his coping strategies for dealing with the challenges of treatment and how his love for films helps keep the spirits up. Mr. Ramendra Kumar, a motivational speaker and award winning author was diagnosed with Colon cancer in Nov 2021. Since then he has been coping with the challenges of colon cancer and the treatment.   Read about Ramendra Kumar Part 1 and Part 2 or watch the video…
  • A panel discussion on Kidney Cancer with the profile pictures of the panelists
    Demystifying Kidney Cancer : Key Webinar takeaways
    Renal cell carcinoma is the most common type of adult kidney cancer, making up about 85% of diagnoses. And yet it is rarely talked about.  Kidney Cancer is also an area which has seen significant progress in treatment options. Key takeaways from the webinar are given below.  An expert panel talked about kidney cancer and answered questions and concerns that patients have. The panelists are Dr. KL Jayakumar, MD Radiation Oncology. Professor and HOD, Sreemookambika Cancer center,…
  • Mukta holding a bouquet of white flowers and a pink ribbon as a design element for breast cancer
    From Being A Caregiver To A Breast Cancer Patient
    Mukta Bhonsule, 55 was diagnosed with stage 3 breast cancer 9 years ago in Mumbai. She shares her journey with breast cancer, the survivorship issues she deals with and the challenges of balancing this as a caregiver of a COPD patient. I was diagnosed with Grade 3 Stage 2A Breast Cancer(HER 2+) in May 2013. What were your early symptoms. I was on a holiday in Goa and it was very hot there. When I got back, I had itching in my breast which I thought was due to heat and sweat. I spoke to my…
  • Webinar: Towards Patient Centred Access To Quality Cancer Care - Challenges
    PatientsEngage and EHA Consortium invite you to an interactive webinar series on Patient Centred Access to Quality Cancer Care. In the first of the series aligned to the UICC theme of "Close the Care Gap", we are very privileged to have an esteemed and diverse panel who will highlight the challenges faced in equitable access to quality cancer care and identify the areas where we still need to make progress. The panelists are Dr. CS Pramesh, Director Tata Memorial Hospital; Convener National…